Heico Companies- Community and Innovation
Stenograph, the industry leader in providing writing solutions for stenographers, emphasizes the importance of customer feedback to enhance their products and improve the lives of their users. They actively seek input from stenographers to identify areas where they can make advancements. This feedback is then utilized to develop a range of innovative solutions. One notable…
Latest
Heico Companies- Community and Innovation
Stenograph’s Collaboration with Steno: Empowering Students for Success in Core Reporting
Stenograph recognizes the commendable efforts of Project Steno in fostering the growth of aspiring professionals in the core reporting industry. Project Steno’s proactive approach of recruiting and evaluating students at the high school level, as they enter core reporting schools, has caught Stenograph’s attention. As a result, Stenograph has formed a strategic partnership with Project…
Heico Companies- Community and Innovation
Meet Your Dedicated Team at Stenograph
We have a dedicated team of professionals who are ready to assist you with all your Steno and voice reporting requirements. Many of our sales staff members have experience as court reporters themselves, which gives them a deep understanding of your work and needs. Our inside sales representatives engage with customers over the phone,…
Heico Companies- Community and Innovation
Navigating Supply Chain Constraints: Stenograph’s Innovative Approaches and Uncompromised Quality
Due to the supply chain constraints experienced by many, we have implemented several strategies to mitigate the impact. They have pursued dual sourcing or multi-sourcing of components, reaching out to vendors overseas and utilizing their extensive network. Additionally, Stenograph has modified electronic components and rewritten software to accommodate the unavailability of certain components by…
Latest
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
Growing the Future of Cancer Research: Inside the Promise of Organoids
In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…
Shaping the Future of Cancer Care Through Immuno-Oncology
In the ever-evolving world of cancer treatment, immuno-oncology (IO) continues to stand at the forefront of innovation. With recent FDA approvals for TIL therapies and bispecific antibodies, and new developments in CAR-T technologies, the field is rapidly expanding into combination-based strategies that integrate with standard care. Researchers are also exploring how to overcome challenges posed…
Evolving Biomarkers: Charting the Future of Precision Medicine
In a rapidly shifting landscape of personalized medicine, biomarkers have become central to shaping the way drug development and clinical trials unfold. From predicting therapeutic response to identifying optimal patient populations, the complexity and scope of biomarker use has increased alongside technological advances. A key success story like the BCR-ABL biomarker in chronic myeloid leukemia…
